Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
Br J Pharmacol. 2011 Nov;164(5):1469-78. doi: 10.1111/j.1476-5381.2011.01424.x.
The detailed molecular modulation of inward rectifier potassium channels (including the K(IR) 2.3 channel) is not fully understood. The present study was designed to determine whether human K(IR) 2.3 (K(IR) 2.3) channels were regulated by protein tyrosine kinases (PTKs).
Whole-cell patch voltage-clamp, immunoprecipitation, Western blot analysis and site-directed mutagenesis were employed to determine the potential PTK phosphorylation of Kir2.3 current in HEK 293 cells stably expressing Kir2.3 gene.
The broad-spectrum PTK inhibitor genistein (10 µM) and the selective epidermal growth factor (EGF) kinase inhibitor AG556 (10 µM) reversibly decreased K(IR) 2.3 current and the effect was reversed by the protein tyrosine phosphatase inhibitor, orthovanadate (1 mM). Although EGF (100 ng·mL(-1) ) and orthovanadate enhanced K(IR) 2.3 current, this effect was antagonized by AG556. However, the Src-family tyrosine kinase inhibitor PP2 (10 µM) did not inhibit K(IR) 2.3 current. Tyrosine phosphorylation of K(IR) 2.3 channels was decreased by genistein or AG556, and was increased by EGF or orthovanadate. The decrease of tyrosine phosphorylation of K(IR) 2.3 channels by genistein or AG556 was reversed by orthovanadate or EGF. Interestingly, the response of K(IR) 2.3 channels to EGF or AG556 was lost in the K(IR) 2.3 Y234A mutant channel.
These results demonstrate that the EGF receptor tyrosine kinase up-regulates the K(IR) 2.3 channel via phosphorylation of the Y234 residue of the WT protein. This effect may be involved in the endogenous regulation of cellular electrical activity.
内向整流钾通道(包括 K(IR)2.3 通道)的详细分子调节尚不完全清楚。本研究旨在确定人 K(IR)2.3(K(IR)2.3)通道是否受蛋白酪氨酸激酶(PTKs)调节。
采用全细胞片钳电压钳、免疫沉淀、Western blot 分析和定点突变技术,检测稳定表达 Kir2.3 基因的 HEK 293 细胞中 Kir2.3 电流的潜在 PTK 磷酸化。
广谱 PTK 抑制剂金雀异黄素(10 μM)和选择性表皮生长因子(EGF)激酶抑制剂 AG556(10 μM)可逆性地降低了 K(IR)2.3 电流,而蛋白酪氨酸磷酸酶抑制剂正钒酸钠(1 mM)则可逆转这一作用。虽然 EGF(100 ng·mL(-1))和正钒酸钠增强了 K(IR)2.3 电流,但这一作用被 AG556 拮抗。然而,Src 家族酪氨酸激酶抑制剂 PP2(10 μM)并不能抑制 K(IR)2.3 电流。金雀异黄素或 AG556 降低 K(IR)2.3 通道的酪氨酸磷酸化,而 EGF 或正钒酸钠则增加其酪氨酸磷酸化。金雀异黄素或 AG556 降低 K(IR)2.3 通道的酪氨酸磷酸化可被正钒酸钠或 EGF 逆转。有趣的是,K(IR)2.3 通道对 EGF 或 AG556 的反应在 K(IR)2.3 Y234A 突变通道中丧失。
这些结果表明,EGF 受体酪氨酸激酶通过 WT 蛋白 Y234 残基的磷酸化而上调 K(IR)2.3 通道。这种作用可能参与了细胞电活动的内源性调节。